| Ytd | -90.05% | |
| 1y | -94.59% |
| Open | 0.18 | Prev Close | 0.18 | Low | 0.17 | High | 0.18 | Mkt Cap | 2.99M |
| Vol | 334.51K | Avg Vol | 5.85M | EPS | -4.47 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.49 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 0.28 | 200-d Avg | 1.22 | 1yr Est | 0.00 |
VIVS News
The FDA’s new rule replaces the term "animal tests" with "nonclinical tests" across
As the FDA opens the door to non-animal safety testing, VivoSim's human-relevant models are already
iSpecimen (NASDAQ: ISPC - Get Free Report) and VivoSim Labs (NASDAQ: VIVS - Get Free Report) are bot
New data presented in Vienna highlights long-term repeat-dose modeling, mechanistic GI barrier profi
VivoSim Labs, Inc. (NASDAQ:VIVS) (the "Company" or "VivoSim"), a provider of next-ge
New cross-species capability is designed to help pharma distinguish rat-specific liver toxicity from
Avalon Holdings (NYSE:AWX) shares rose 10.5% in pre-market trading after posting strong Q2 earnings
SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “Vi
Gainers Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-
, Inc. (NASDAQ:VIVS) (the "Company" or "VivoSim"), a provider of next-generation New
Initial customer wins bring VivoSim's human-relevant liver and GI testing to the world's second-larg
Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's
VivoSim Labs (VIVS) stock plunges over 25% on a $4M private placement priced at $0.85/share. Read ab
VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-g
SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "Vi
JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7
Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday
VivoSim Labs shares climbed after receiving a $5 million Eli Lilly milestone payment and forecasting
VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-g
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “Vi
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's
The presentations collectively showcase the best-in-industry predictive power of VivoSim's propr
SAN DIEGO, June 29, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "Vi
VivoSim's NAMkind™ Intestinal Model combined with AI prediction tools yields high-accuracy results V
VivoSim Labs, Inc. (NASDAQ: VIVS - Get Free Report) was the target of a large decline in short inter
VivoSim Labs, Inc. (NASDAQ:VIVS), (the "Company" or "VivoSim"), a provider of next-g
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS), (the “Company” or “
VivoSim Labs (NASDAQ: VIVS - Get Free Report) and Agenus (NASDAQ: AGEN - Get Free Report) are both s
ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload
VivoSim Labs, Inc. (NASDAQ: VIVS - Get Free Report) saw a significant drop in short interest in the
Veteran business development leader with deep expertise in human-relevant NAM and spheroid-based in
VivoSim Labs, Inc. (NASDAQ: VIVS - Get Free Report) was the recipient of a large decrease in short i
Company produces thorough reference testing on Antibody Drug Conjugates, showing high correlation wi
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “Vi
